Back to Search
JERRY WONG, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1285935585IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
A163242(CA)
Hematology (Pathology) Physician
Pathology — Hematology
Code: 207ZH0000X
136242(CA)
Clinical Pathology Physician
Pathology — Clinical Pathology
Code: 207ZC0006X
288002(NY)
CMS Specialties
PrimaryPATHOLOGY
Education
UNIVERSITY OF CALIFORNIA, IRVINE, CALIFORNIA COLLEGE OF MEDICINE
Class of 2010
Research & Publications (20)
Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation.
PMID 18786784·Int J Radiat Oncol Biol Phys·2009
3-trial
Systemic targeted radionuclide therapy: potential new areas.
PMID 16979445·Int J Radiat Oncol Biol Phys·2006
6-review
A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.
PMID 16706629·Cancer Biother Radiopharm·2006
3-trial
Basic immunology of antibody targeted radiotherapy.
PMID 16979446·Int J Radiat Oncol Biol Phys·2006
6-review
Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation.
PMID 16503500·Biol Blood Marrow Transplant·2006
4-observational
Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
PMID 15297402·Clin Cancer Res·2004
3-trial
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
PMID 14676105·Clin Cancer Res·2003
3-trial
Evaluating changes in stable chromosomal translocation frequency in patients receiving radioimmunotherapy.
PMID 10701739·Int J Radiat Oncol Biol Phys·2000
3-trial
A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells.
PMID 19560263·Cancer Lett·2010
8-other
A carboxy-terminal affinity tag for the purification and mass spectrometric characterization of integral membrane proteins.
PMID 19236039·J Proteome Res·2009
7-preclinical
Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.
PMID 19231099·Int J Radiat Oncol Biol Phys·2009
8-other
Immediate pain relief and improved structural stability after percutaneous vertebroplasty for a severely destructive vertebral compression fracture.
PMID 19284275·J Palliat Med·2009
5-case
Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications.
PMID 19629432·Diabetologia·2009
8-other
Distinguishing between inhibitory and episodic processing accounts of switch-cost asymmetries.
PMID 19271811·Can J Exp Psychol·2009
8-other
ETISEQ--an algorithm for automated elution time ion sequencing of concurrently fragmented peptides for mass spectrometry-based proteomics.
PMID 19664259·BMC Bioinformatics·2009
7-preclinical
Studies on an antifungal protein and a chromatographically and structurally related protein isolated from the culture broth of Bacillus amyloliquefaciens.
PMID 19508197·Protein Pept Lett·2009
8-other
Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses.
PMID 19355966·Curr Pharm Des·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 EAST DUARTE ROAD
DUARTE, CA 91010 - Phone
- (626) 256-4673
Quick Facts
- NPI
- 1285935585
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile